Medicare Enrolled
Dr. Mayank Pathak, M.D.
Neurology · Orange, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pathak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pathak?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pathak
Dr. Mayank Pathak is a neurology specialist in Orange, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Pathak performed 8,147 Medicare services across 651 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pathak received a total of $30,675 from 96 pharmaceutical and/or device companies across 1639 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pathak is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 11% volume in CA
$30,675 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,147
Medicare services
Top 11% in CA for neurology
651
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~429 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
6,805 | $5 | $7 |
| Continuous intraoperative neurophysiology monitoring, remote Remote monitoring of nerve and brain function during surgery, billed in 15-minute increments. |
553 | $27 | $75 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
291 | $95 | $153 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
169 | $95 | $153 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
91 | $143 | $350 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs This procedure involves placing skin electrodes and measuring stimulated sites on the arms and legs. |
60 | $38 | $397 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
58 | $32 | $100 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
57 | $122 | $389 |
| Electromyography of 2 extremities A test that measures the electrical activity in the muscles of two arms or legs. It helps evaluate nerve and muscle function. |
42 | $68 | $400 |
| Central motor stimulation test of arms and legs This procedure involves placing skin electrodes on the body to measure how the central nervous system stimulates the muscles in the arms and legs. |
21 | $99 | $400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$30,675
Total received (2018-2024)
Avg $4,382/year across 7 years
Top 11% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
96
Companies
1,639
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$30,350 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$325 (1.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,695
2023
$4,678
2022
$4,652
2021
$4,179
2020
$3,167
2019
$4,314
2018
$3,989
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,221
UCB, Inc.
$516
Novartis Pharmaceuticals Corporation
$364
SK Life Science, Inc.
$301
Alexion Pharmaceuticals, Inc.
$293
PFIZER INC.
$279
Biogen, Inc.
$243
Neurocrine Biosciences, Inc.
$241
Lilly USA, LLC
$189
MDD US Operations, LLC
$156
Eisai Inc.
$155
Kyowa Kirin, Inc.
$135
Celgene Corporation
$114
Lundbeck LLC
$112
TG Therapeutics, Inc.
$111
EMD Serono, Inc.
$104
Amneal Pharmaceuticals LLC
$97
ACADIA Pharmaceuticals Inc
$93
Ipsen Biopharmaceuticals, Inc
$88
LivaNova USA, Inc.
$78
Grifols USA, LLC
$78
MITSUBISHI TANABE PHARMA AMERICA, INC.
$75
GE HEALTHCARE
$69
Teva Pharmaceuticals USA, Inc.
$56
SCILEX PHARMACEUTICALS INC.
$54
CATALYST PHARMACEUTICALS, INC.
$48
Abbott Laboratories
$46
BANNER LIFE SCIENCES, LLC
$45
JAZZ PHARMACEUTICALS INC.
$42
NEUROPACE, INC.
$38
Vanda Pharmaceuticals Inc.
$36
REVANCE THERAPEUTICS, INC.
$34
Averitas Pharma Inc.
$30
Alnylam Pharmaceuticals Inc.
$27
Takeda Pharmaceuticals U.S.A., Inc.
$27
Medtronic, Inc.
$24
AstraZeneca Pharmaceuticals LP
$24
Merz Pharmaceuticals, LLC
$23
Boston Scientific Corporation
$17
Octapharma USA, Inc.
$14
Top 3 companies account for 36.9% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$2,669
Novartis Pharmaceuticals Corporation
$2,462
Biogen, Inc.
$2,209
SK Life Science, Inc.
$1,185
Neurocrine Biosciences, Inc.
$1,101
UCB, Inc.
$1,094
Supernus Pharmaceuticals, Inc.
$1,071
Sunovion Pharmaceuticals Inc.
$1,044
Alexion Pharmaceuticals, Inc.
$1,016
Lundbeck LLC
$804
EMD Serono, Inc.
$769
Amgen Inc.
$753
Teva Pharmaceuticals USA, Inc.
$714
Lilly USA, LLC
$694
Amneal Pharmaceuticals LLC
$611
GENZYME CORPORATION
$609
PFIZER INC.
$604
Eisai Inc.
$602
Kyowa Kirin, Inc.
$455
ACADIA Pharmaceuticals Inc
$455
Allergan Inc.
$445
CSL Behring
$435
GE HEALTHCARE
$423
MDD US Operations, LLC
$407
Celgene Corporation
$386
Ipsen Biopharmaceuticals, Inc
$374
AbbVie Inc.
$373
Allergan, Inc.
$335
Janssen Pharmaceuticals, Inc
$330
Biohaven Pharmaceuticals, Inc.
$320
Avanir Pharmaceuticals, Inc.
$293
EISAI INC.
$262
Biohaven Pharmaceutical Holding Company Ltd.
$254
Adamas Pharmaceuticals, Inc.
$249
Grifols USA, LLC
$244
Genentech USA, Inc.
$223
Medtronic, Inc.
$209
Merz Pharmaceuticals, LLC
$181
Greenwich Biosciences, Inc.
$170
AstraZeneca Pharmaceuticals LP
$163
Abbott Laboratories
$161
Banner Life Sciences, LLC
$157
Forte Bio-Pharma LLC
$149
BANNER LIFE SCIENCES, LLC
$147
GE Healthcare
$144
MITSUBISHI TANABE PHARMA AMERICA, INC.
$143
Acorda Therapeutics, Inc
$140
Merz North America, Inc.
$132
W. L. Gore & Associates, Inc.
$132
Boston Scientific Corporation
$122
GE HealthCare
$120
US WorldMeds, LLC
$115
TG Therapeutics, Inc.
$111
LivaNova USA, Inc.
$91
CATALYST PHARMACEUTICALS, INC.
$89
TG THERAPEUTICS, INC.
$88
Mallinckrodt Enterprises LLC
$84
Medtronic USA, Inc.
$82
ARGENX US, INC.
$80
PORTOLA PHARMACEUTICALS, INC.
$79
Vertical Pharmaceuticals, LLC
$75
UPSHER-SMITH LABORATORIES LLC
$69
SCILEX PHARMACEUTICALS INC.
$69
Takeda Pharmaceuticals U.S.A., Inc.
$68
Upsher-Smith Laboratories LLC
$67
Amylyx Pharmaceuticals, Inc.
$66
Avion Pharmaceuticals
$64
Impax Laboratories, Inc.
$64
Octapharma USA, Inc.
$64
JAZZ PHARMACEUTICALS INC.
$62
E.R. Squibb & Sons, L.L.C.
$50
Catalyst Pharmaceuticals, Inc.
$41
IMPEL PHARMACEUTICALS INC.
$40
NEUROPACE, INC.
$38
Mitsubishi Tanabe Pharma America, Inc.
$38
Vanda Pharmaceuticals Inc.
$36
REVANCE THERAPEUTICS, INC.
$34
Averitas Pharma Inc.
$30
Neurelis, Inc.
$30
Alnylam Pharmaceuticals Inc.
$27
Corium, LLC
$25
Otsuka America Pharmaceutical, Inc.
$24
Merck Sharp & Dohme Corporation
$24
MERZ NORTH AMERICA, INC.
$21
Sumitomo Pharma America, Inc.
$21
Bausch Health US, LLC
$19
AQUESTIVE THERAPEUTICS, INC.
$19
Xeris Pharmaceuticals, Inc.
$19
Mylan Pharmaceuticals Inc.
$18
Jazz Pharmaceuticals Inc.
$17
AbbVie, Inc.
$16
Alfasigma USA, Inc.
$15
Assertio Therapeutics, Inc.
$14
Bayer HealthCare Pharmaceuticals Inc.
$13
Merck Sharp & Dohme LLC
$13
Travere Therapeutics, Inc.
$2
Top 3 companies account for 23.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADLARITY · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · ANDEXXA · APLENZIN · APOKYN · APTIOM · ARZERRA · AUBAGIO · AUSTEDO · AVONEX · Aduhelm · Aimovig · Apokyn · Austedo XR · BAFIERTAM · BELSOMRA · BEVYXXA · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · CAMBIA · CARDIOFORM Septal Occluder · COMIRNATY · COPAXONE · CREXONT · Cenobamate · Cholbam · DAXI · DAXXIFY · DAYBUE · DISEASE STATE · DIVIGEL · DUOPA · DYSPORT · Dayvigo · Dhivy · Duopa · Dysport · EMGALITY · EVUSHELD · Enspryng · Epidiolex · FIRDAPSE · FYCOMPA · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · General - DBS · Glatiramer Acetate · Gocovri · HYQVIA · Hizentra · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LINZESS · LONHALA MAGNAIR · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nalocet · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PAXLOVID · PERCEPT PC BRAINSENSE · PIPELINE-MS · PLEGRIDY · PONVORY · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · RADICAVA · RELYVRIO · REXULTI · RNS Neurostimulator Kit · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPRAVATO · SUNOSI · SYMPAZAN · Soliris · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VERCISE · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VRAYLAR · VUMERITY · VYALEV · VYEPTI · VYVGART · Vimpat · XARELTO · XCOPRI · XEOMIN · XYWAV · Xadago · Xeomin · ZEPOSIA · ZTLido · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
277
Per 100K population
8.8
County median income
$113,702
Nearest hospital
PROVIDENCE ST. JOSEPH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pathak is a mixed practice specialist, with above-average Medicare volume (top 11% in CA), with low-engagement industry engagement in the top 11% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pathak experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Pathak performed 6,805 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pathak receive payments from pharmaceutical companies?
Yes. Dr. Pathak received a total of $30,675 from 96 companies across 1,639 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pathak's costs compare to other neurologists in Orange?
Dr. Pathak's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pathak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Orange
Browse neurologists in Orange ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology